Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here’s What Hedge Funds Think About Innophos Holdings, Inc. (IPHS)

Before we spend days researching a stock idea we like to take a look at how hedge funds and billionaire investors recently traded that stock. Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by more than 10 percentage points since the end of the third quarter of 2018. This means hedge funds that are allocating a higher percentage of their portfolio to small-cap stocks were probably underperforming the market. However, this also means that as small-cap stocks start to mean revert, these hedge funds will start delivering better returns than the S&P 500 Index funds. In this article, we will take a look at what hedge funds think about Innophos Holdings, Inc. (NASDAQ:IPHS).

Innophos Holdings, Inc. (NASDAQ:IPHS) investors should pay attention to an increase in enthusiasm from smart money in recent months. Our calculations also showed that IPHS isn’t among the 30 most popular stocks among hedge funds (see the video below).
5 Most Popular Stocks Among Hedge Funds
Video: Click the image to watch our video about the top 5 most popular hedge fund stocks.

To the average investor there are a large number of metrics shareholders put to use to evaluate stocks. Some of the most under-the-radar metrics are hedge fund and insider trading indicators. Our researchers have shown that, historically, those who follow the top picks of the elite hedge fund managers can outclass the S&P 500 by a very impressive amount (see the details here).

IPHS_oct2019

Unlike former hedge manager, Dr. Steve Sjuggerud, who is convinced Dow will soar past 40000, our long-short investment strategy doesn’t rely on bull markets to deliver double digit returns. We only rely on hedge fund buy/sell signals. We’re going to take a look at the key hedge fund action surrounding Innophos Holdings, Inc. (NASDAQ:IPHS).

How have hedgies been trading Innophos Holdings, Inc. (NASDAQ:IPHS)?

Heading into the third quarter of 2019, a total of 12 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of 9% from one quarter earlier. The graph below displays the number of hedge funds with bullish position in IPHS over the last 16 quarters. With the smart money’s positions undergoing their usual ebb and flow, there exists an “upper tier” of key hedge fund managers who were boosting their holdings significantly (or already accumulated large positions).

Roger Ibbotson Zebra Capital

More specifically, Renaissance Technologies was the largest shareholder of Innophos Holdings, Inc. (NASDAQ:IPHS), with a stake worth $25.3 million reported as of the end of March. Trailing Renaissance Technologies was Arrowstreet Capital, which amassed a stake valued at $4.6 million. D E Shaw, Citadel Investment Group, and Two Sigma Advisors were also very fond of the stock, giving the stock large weights in their portfolios.

Consequently, specific money managers were leading the bulls’ herd. Fondren Management, managed by Bradley Louis Radoff, initiated the biggest position in Innophos Holdings, Inc. (NASDAQ:IPHS). Fondren Management had $0.6 million invested in the company at the end of the quarter. Roger Ibbotson’s Zebra Capital Management also initiated a $0.2 million position during the quarter. The only other fund with a new position in the stock is Benjamin A. Smith’s Laurion Capital Management.

Let’s go over hedge fund activity in other stocks similar to Innophos Holdings, Inc. (NASDAQ:IPHS). We will take a look at Digimarc Corp (NASDAQ:DMRC), Maxar Technologies Inc. (NYSE:MAXR), New Media Investment Group Inc (NYSE:NEWM), and LeMaitre Vascular Inc (NASDAQ:LMAT). All of these stocks’ market caps match IPHS’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
DMRC 6 50230 3
MAXR 12 43172 5
NEWM 14 52864 -3
LMAT 11 20419 0
Average 10.75 41671 1.25

View table here if you experience formatting issues.

As you can see these stocks had an average of 10.75 hedge funds with bullish positions and the average amount invested in these stocks was $42 million. That figure was $39 million in IPHS’s case. New Media Investment Group Inc (NYSE:NEWM) is the most popular stock in this table. On the other hand Digimarc Corp (NASDAQ:DMRC) is the least popular one with only 6 bullish hedge fund positions. Innophos Holdings, Inc. (NASDAQ:IPHS) is not the most popular stock in this group but hedge fund interest is still above average. Our calculations showed that top 20 most popular stocks among hedge funds returned 24.4% in 2019 through September 30th and outperformed the S&P 500 ETF (SPY) by 4 percentage points. Hedge funds were also right about betting on IPHS as the stock returned 13.5% during the third quarter and outperformed the market. Hedge funds were rewarded for their relative bullishness.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.